Indication

Vulvar Atrophy

1 clinical trial

1 product

Clinical trial

Phase 1/2 Study of Intravaginal Tamoxifen (DARE-VVA1): Randomized, Double-blind, Placebo-controlled Study of Safety, Pharmacokinetics and Pharmacodynamics in Postmenopausal Participants With Moderate to Sever Vulvar and Vaginal Atrophy

Status: Completed, Estimated PCD: 2022-12-20

Product